Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2010-04-27 | William S. Reardon (63), Trustee, HQH and HQL; No committee memberships mentioned; Compensation not stated. |
| 2011-06-08 | Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCooper ("PwC"), with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides the Trustees of the Fund, and especially the Valuation Committee with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. ... He serves on the Valuation Committee of the Fund. ... Compensation Table ... William S. Reardon ... Total Compensation ... $4,400 |
| 2012-04-30 | William S. Reardon, CPA: Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCooper ("PwC"), with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides the Trustees of the Fund, and especially the Valuation Committee with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. |
| 2013-04-25 | William S. Reardon: Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP ("PwC"), with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides the Trustees of the Fund, and especially the Valuation Committee, with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. He serves on the Valuation and Audit Committees of the Fund. ... Compensation Table For the fiscal year ended September 30, 2012 ... William S. Reardon $27,500 + $27,500 = $55,000 total compensation. |
| 2018-04-18 | William S. Reardon: Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP ("PwC"), with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides each Fund with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. He serves on the Valuation Committee and as Chair of the Audit Committee of each Fund. |
| 2019-04-15 | Mr. Reardon serves on the Valuation Committee and as Chair of the Audit Committee of each Fund... The members of each Fund's Audit Committee are Mr. Kent, Dr. Nabel, Mr. Reardon and Ms. Stebbins. Mr. Reardon is the Chairman of each Fund's Audit Committee... The members of each Fund's Valuation Committee are Mr. Kent, Dr. Omstead, Mr. Pohotsky and Mr. Reardon... The members of each Fund's QLCC are Dr. Jain, Mr. Pohotsky and Mr. Reardon. Mr. Reardon is the Chairman of each Fund's QLCC... For the fiscal year ended September 30, 2018... William S. Reardon... $105,750. |
| 2020-04-14 | Mr. Reardon serves on the Valuation Committee and as Chair of the Audit Committee of each Fund. ... Mr. Reardon is the Chairman of each Fund's Audit Committee. ... William S. Reardon total compensation $108,000. |
| 2021-04-13 | William S. Reardon: Mr. Reardon serves on the Valuation Committee and as Chair of the Audit Committee of each Fund. He is also a member of each Fund's Qualified Legal Compliance Committee. Compensation Table shows William S. Reardon total compensation from all funds as $107,000. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-04-27 | Partner, PricewaterhouseCoopers LLP (1980-2002); Director, Idera Pharmaceuticals, Inc. (since 2002); Director, Synta Pharmaceuticals Corp. (since 2004); Director, Oscient Pharmaceuticals Corporation (since 2003). |
| 2011-06-08 | Mr. Reardon was a Life Science audit partner at PricewaterhouseCooper and has an MBA from Harvard Business School. |
| 2018-04-18 | Mr. Reardon was a business assurance partner in PwC's Boston office and leader of the Life Sciences Industry Practice. |
| 2019-04-15 | Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP... He has an MBA from Harvard Business School and a BA in East Asian History from Harvard College. |
| 2020-04-14 | Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP... He provides each Fund with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. |
| 2021-04-13 | Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP... He holds an MBA from Harvard Business School and a BA in East Asian History from Harvard College. |
Data sourced from SEC filings. Last updated: 2025-10-12